Compounds for the treatment of metabolic disorders
2008
The present invention has dual activity as inhibitors of agonists and DPP-IV of GPRl 19, metabolic disorders, related therapeutic compounds such as useful for the treatment of type II diabetes.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI